Better Therapeutics (BTTX) Institutional Ownership $0.0001 0.00 (0.00%) (As of 01:24 PM ET) Add Compare Share Share Ownership Stock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends Institutional Ownership Changes (13F Filings) for Better Therapeutics (NASDAQ:BTTX)CurrentInstitutional OwnershipPercentage34.00%Number ofInstitutional Buyers(last 12 months)0Number ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$239.23K Get BTTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Better Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data BTTX Institutional Buying and Selling by Quarter Ad Priority GoldJD Vance Predicts: Wall Street vs. Trump & Your MoneyTrump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. Better Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/12/2024 MMCAP International Inc. SPC356,270$65K0.0%-77.5%0.715% 11/14/2023 MMCAP International Inc. SPC1,583,079$579K0.2%N/A3.340% 5/15/2023 Farallon Capital Management LLC699,042$509K0.0%-14.1%2.931% 5/10/2022 Sectoral Asset Management Inc.878,531$1.74M0.3%-9.8%3.721% 5/4/2022 Victory Capital Management Inc.272,720$540K0.0%N/A1.155% (Data available from 1/1/2016 forward) BTTX Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of BTTX shares? During the previous two years, the following institutional investors and hedge funds held shares of Better Therapeutics shares: Farallon Capital Management LLC ($509K), MMCAP International Inc. SPC ($65K).Learn more on BTTX's institutional investors. What percentage of Better Therapeutics stock is owned by institutional investors? 34.00% of Better Therapeutics stock is owned by institutional investors. Learn more on BTTX's institutional investor holdings. Which institutional investors have been buying Better Therapeutics stock? The following institutional investors have purchased Better Therapeutics stock in the last 24 months: MMCAP International Inc. SPC ($1.58M). How much institutional buying is happening at Better Therapeutics? Institutional investors have bought a total of 1,583,079 shares in the last 24 months. This purchase volume represents approximately $579.41K in transactions. Which Better Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Better Therapeutics stock in the last 24 months: MMCAP International Inc. SPC ($1.23M), and Farallon Capital Management LLC ($114.51K). How much institutional selling is happening at Better Therapeutics? Institutional investors have sold a total of 1,341,323 shares in the last 24 months. This volume of shares sold represents approximately $319.39K in transactions. Related Companies AONC Major Shareholders SHCRW Major Shareholders BFI Major Shareholders NTRA Major Shareholders FMS Major Shareholders HIMS Major Shareholders OPCH Major Shareholders GH Major Shareholders SHC Major Shareholders BTSG Major Shareholders This page (NASDAQ:BTTX) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Better Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Better Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
